Remedial strategies in structural proteomics: Expression, purification, and crystallization of the Vav1/Rac1 complex

被引:7
作者
Brooun, Alexei
Foster, Scott A.
Chrencik, Jill E.
Chien, Ellen Y. T.
Kolatkar, Anand R.
Streiff, Markus
Ramage, Paul
Widmer, Hans
Weckbecker, Gisbert
Kuhn, Peter
机构
[1] Scripps Res Inst, Dept Cellular Biol, La Jolla, CA 92037 USA
[2] NIBR, Novartis Inst BioMed Res, CH-4002 Basel, Switzerland
关键词
guanine nucleotide exchange factor; structural proteomics; cysteine-rich segment; protein-protein interaction; surface mutagenesis;
D O I
10.1016/j.pep.2006.10.027
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The signal transduction pathway involving the Vav1 guanine nucleotide exchange factor (GEF) and the Racl GTPase plays several key roles in the immune response mediated by the T cell receptor. Vav1 is also a unique member of the GEF family in that it contains a cysteine-rich domain (CRD) that is critical for Racl binding and maximal guanine nucleotide exchange activity, and thus may provide a unique protein protein interface compared to other GEF/GTPase pairs. Here, we have applied a number of remedial structural proteomics strategies, such as construct and expression optimization, surface mutagenesis, limited proteolysis, and protein formulation to successfully express, purify, and crystallize the Vav1-DH-PH-CRD/Rac1 complex in an active conformation. We have also systematically characterized various Vav1 domains in a GEF assay and Rac1 in vitro binding experiments. In the context of Vav1-DH-PH-CRD, the zinc finger motif of the CRD is required for the expression of stable Vav1, as well as for activity in both a GEF assay and in vitro formation of a Vav1/Rac1 complex suitable for biophysical and structural characterization. Our data also indicate that the isolated CRD maintains a low level of specific binding to Rac1, appears to be folded based on 1D NMR analysis and coordinates two zinc ions based on ICP-MS analysis. The protein reagents generated here are essential tools for the determination of a three dimensional Vav1/Rac1 complex crystal structure and possibly for the identification of inhibitors of the Vav1/Rac1 protein-protein interaction with potential to inhibit lymphocyte activation. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:51 / 62
页数:12
相关论文
共 35 条
[1]   Structural basis for relief of autoinhibition of the Dbl homology domain of proto-oncogene Vav by tyrosine phosphorylation [J].
Aghazadeh, B ;
Lowry, WE ;
Huang, XY ;
Rosen, MK .
CELL, 2000, 102 (05) :625-633
[2]   Acidic region tyrosines provide access points for allosteric activation of the autoinhibited Vav1 Dbl homology domain [J].
Amarasinghe, GK ;
Rosen, MK .
BIOCHEMISTRY, 2005, 44 (46) :15257-15268
[3]   Protein-protein interactions and cancer: small molecules going in for the kill [J].
Arkin, M .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2005, 9 (03) :317-324
[4]   Critical but distinct roles for the pleckstrin homology and cysteine-rich domains as positive modulators of Vav2 signaling and transformation [J].
Booden, MA ;
Campbell, SL ;
Der, CJ .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (08) :2487-2497
[5]   Vav proteins, adaptors and cell signaling [J].
Bustelo, XR .
ONCOGENE, 2001, 20 (44) :6372-6381
[6]   Crystal structure of aurora-2, an oncogenic serine/threonine kinase [J].
Cheetham, GMT ;
Knegtel, RMA ;
Coll, JT ;
Renwick, SB ;
Swenson, L ;
Weber, P ;
Lippke, JA ;
Austen, DA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (45) :42419-42422
[7]   The crystal structure of RhoA in complex with the DH/PH fragment of PDZRhoGEF, an activator of the Ca2+ sensitization pathway in smooth muscle [J].
Derewenda, U ;
Oleksy, A ;
Stevenson, AS ;
Korczynska, J ;
Dauter, Z ;
Somlyo, AP ;
Otlewski, J ;
Somlyo, AV ;
Derewenda, ZS .
STRUCTURE, 2004, 12 (11) :1955-1965
[8]   Ras interaction with two distinct binding domains in Raf-1 may be required for Ras transformation [J].
Drugan, JK ;
KhosraviFar, R ;
White, MA ;
Der, CJ ;
Sung, YJ ;
Hwang, YW ;
Campbell, SL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (01) :233-237
[9]   Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis [J].
Fernandez-Zapico, ME ;
Gonzalez-Paz, NC ;
Weiss, E ;
Savoy, DN ;
Molina, JR ;
Fonseca, R ;
Smyrk, TC ;
Chari, ST ;
Urrutia, R ;
Billadeau, DD .
CANCER CELL, 2005, 7 (01) :39-49
[10]   Rational design and characterization of a Rac GTPase-specific small molecule inhibitor [J].
Gao, Y ;
Dickerson, JB ;
Guo, F ;
Zheng, J ;
Zheng, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (20) :7618-7623